Supply of Fexofenadine Hydrochloride Tablets (NSN 6505015139739)

The contract entails the manufacture and supply of two bottles of Fexofenadine Hydrochloride Tablets, each containing 30 mg of the active ingredient, to meet stringent regulatory and quality standards including FDA requirements, current Good Manufacturing Practices, and Defense Logistics Agency specifications. The product must be fully traceable to the designated manufacturer identified by CAGE code 1LEZO, ensuring accountability and compliance throughout the supply chain. This procurement is linked to the National Stock Number 6505015139739 and falls under NAICS Code 325412, classifying it within pharmaceutical and medicine manufacturing. The agreement is structured as a subcontract under the Department of Defense, specifically managed by the Defense Logistics Agency, with the solicitation tied to contract SPE2DX25D9900 and delivery order SPE2DP26F8714, indicating a formalized military supply chain requirement. The posting date of August 5, 2026, suggests this is a forward-looking procurement aimed at securing essential medications for defense medical readiness.